Exploring Protein-Based Carriers in Drug Delivery: A Review
Pharmaceutics · 05.09.2024 · 16 (9) · 1172
DOI: 10.3390/pharmaceutics16091172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 05.09.2024. Verfasst von Claudia Ferraro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug delivery systems (DDSs) represent an emerging focus for many researchers and they are becoming progressively crucial in the development of new treatments. Great attention is given to all the challenges that a drug has to overcome during its journey across barriers and tissues and all the pharmacokinetics modulations that are needed in order to reach the targeting sites. The goal of these pathways is the delivery of drugs in a controlled way, optimizing their bioavailability and minimizing side effects. Recent innovations in DDSs include various nanotechnology-based approaches, such as nanoparticles, nanofibers and micelles, which provide effective targeted delivery and sustained release of therapeutics. In this context, protein-based drug delivery systems are gaining significant attention in the pharmaceutical field due to their potential to revolutionize targeted and efficient drug delivery. As natural biomolecules, proteins offer distinct advantages, including safety, biocompatibility and biodegradability, making them a fascinating alternative to synthetic polymers. Moreover, protein-based carriers, including those derived from gelatin, albumin, collagen, gliadin and silk proteins, demonstrate exceptional stability under physiological conditions, and they allow for controlled and sustained drug release, enhancing therapeutic efficacy. This review provides a comprehensive overview of the current trends, challenges, and future perspectives in protein-based drug delivery, focusing on the types of proteins adopted and the techniques that are being developed to enhance their functionality in terms of drug affinity and targeting capabilities, underscoring their potential to significantly impact modern therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy.
- Macrofarm s.r.l., c/o Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy.
ORCID-Profile: Claudia Ferraro, Marco Dattilo, Francesco Patitucci, Giuseppe Scopelliti, Ortensia Ilaria Parisi, Francesco Puoci
Zitieren
APA
Ferraro, C., Dattilo, M., Patitucci, F., Prete, S., Scopelliti, G., Parisi, O. I., & Puoci, F. (2024). Exploring Protein-Based Carriers in Drug Delivery: A Review. Pharmaceutics, 16(9), 1172. https://doi.org/10.3390/pharmaceutics16091172
Vancouver
Ferraro C, Dattilo M, Patitucci F, Prete S, Scopelliti G, Parisi OI, et al. Exploring Protein-Based Carriers in Drug Delivery: A Review. Pharmaceutics. 2024;16(9):1172. doi:10.3390/pharmaceutics16091172
BibTeX
@article{Ferraro2024,
author = {Ferraro, Claudia and Dattilo, Marco and Patitucci, Francesco and Prete, Sabrina and Scopelliti, Giuseppe and Parisi, Ortensia Ilaria and Puoci, Francesco},
title = {Exploring Protein-Based Carriers in Drug Delivery: A Review},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {9},
pages = {1172},
doi = {10.3390/pharmaceutics16091172}
}
EUVIMED